Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Noboru Ueba is active.

Publication


Featured researches published by Noboru Ueba.


Chemotherapy | 1991

Inhibitory effect of tachyplesin I on the proliferation of human immunodeficiency virus in vitro

Motoko Morimoto; Haruyo Mori; Toru Otake; Noboru Ueba; Nobuharu Kunita; Makoto Niwa; Tukasa Murakami; Sadaaki Iwanaga

An antimicrobial peptide, tachyplesin I, isolated from hemocytes of the Japanese horseshoe crab (Tachypleus tridentatus) was examined for its inhibitory effects on human immunodeficiency virus (HIV) infection in vitro. At a concentration of 7.5 micrograms/ml, tachyplesin I suppressed the development of cytopathic effects (CPE) by more than 70% in MT-4 cells infected with HIV (lymphadenopathy-associated virus). This inhibitory effect was observed only when the drug was added during the adsorption period of the virus to the cells. In cocultures of MOLT-4 and persistently HIV-infected cells (MOLT-4/HIV), tachyplesin I at the same concentration completely inhibited multinucleated giant cell formation. Infectivity of HIV was reduced by 10(-2.5) in medium free from fetal calf serum containing tachyplesin I at a concentration of 200 micrograms/ml. Tachyplesin I did not show any inhibitory effect on reverse transcriptase activity of HIV at concentrations of 9-80 micrograms/ml at which tachyplesin I inhibited HIV infection. These results suggest that the anti-HIV action of tachyplesin I was due to the inhibition of virus adsorption.


Antiviral Research | 1991

Anti-HIV-1 activity of sulfated amphotericin B in vitro

Toru Otake; Keiichi Miyano; Haruyo Mori; Motoko Morimoto; Noboru Ueba; Nobuharu Kunita; Hideki Nakashima; Takashi Kurimura

To reduce the toxicity of amphotericin B methyl ester (AME), which shows some anti-HIV-1 activity, sulfated amphotericin B (SAB) was prepared from amphotericin B (AB), and its anti-HIV-1 activity was examined in vitro. SAB at concentration of 7.8 micrograms/ml completely suppressed the HIV-1-induced cytopathic effect in MT-4 cells, at 3.9 micrograms/ml inhibited the expression of HIV-1 antigen in peripheral blood mononuclear cells infected with freshly isolated HIV-1 and at 22 micrograms/ml completely suppressed formation of giant cells in cocultures of MOLT-4 with MOLT-4/HIV-1 cells. Reverse transcriptase activity was inhibited by SAB, but only at higher concentrations (0.2-1 mg/ml). Furthermore, the toxicity of SAB was lower than that of AME or AB, and SAB did not affect the proliferation of MT-4 cells at concentrations up to 0.5 mg/ml. The anti-coagulant effect of SAB was 10-fold less than that of dextran sulfate (MW = 8000). The anti-HIV-1 effect of SAB is attributed to inhibition of binding of virions to target cells.


The Journal of the Japanese Association for Infectious Diseases | 1990

A Rapid Method for Serodiagnosis of Japanese Encephalitis using Persistently Infected C6/J-121 Cells

Tomoaki Kimura; Toru Otake; Noboru Ueba; Yoshiichi Minekawa

The usefulness of persistently infected C6/36 (C6/J-121) cells with Japanese encephalitis virus (JEV) for a rapid serodiagnostic test was examined with the sera of men, swine and laboratory animals by indirect immunofluorescent antibody (IFA) technique. Detection of specific antibodies was completed within 3 to 5 hours. Nonspecific fluorescence frequently observed in other IFA tests was few. The sensitivity of antibody detection and the serological specificity of IFA (IgG) were similar to those of hemagglutination-inhibition (HI) test. For the detection of IgM antibodies in sera of JE-patients and naturally JEV infected swine, this method was found to be simpler and more sensitive and rapid than the conventional HI test which required 2-ME treatment of the sera.


Journal of Medicinal Chemistry | 1991

Potent inhibitory effect of a series of modified cyclodextrin sulfates (mCDS) on the replication of HIV-1 in vitro.

Tamon Moriya; Hironori Kurita; Kazuo Matsumoto; Toru Otake; Haruyo Mori; Motoko Morimoto; Noboru Ueba; Nobuharu Kunita


Journal of Medicinal Chemistry | 1993

A new candidate for an anti-HIV-1 agent: modified cyclodextrin sulfate (mCDS71).

Tamon Moriya; Kiyosi Saito; Hironori Kurita; Kazuo Matsumoto; Toru Otake; Haruyo Mori; Motoko Morimoto; Noboru Ueba; Nobuharu Kunita


Japanese Journal of Cancer Research | 1991

In vitro Anti‐human Immunodeficiency Virus Type 1 Activity of Biliverdin, a Bile Pigment

Haruyo Mori; Toru Otake; Motoko Morimoto; Noboru Ueba; Nobuharu Kunita; Tatsuyoshi Nakagami; Non Yamasaki; Shiro Taji


Medical Entomology and Zoology | 2002

Ecological studies on Japanese encephalitis (JE) in Osaka Prefecture 6. Surveillance of JE virus activity and the vector mosquito abundance during the years 1968-1997

Hiroshi Nakamura; Masahiro Yoshida; Akio Kimura; Takahiro Yumisashi; Tomoaki Kimura; Noboru Ueba; Nobuharu Kunita


The Journal of the Japanese Association for Infectious Diseases | 1990

HIV Isolation and Clinical Markers on the Seropositive Subjects

Toru Otake; Haruyo Mori; Motoko Morimoto; Noboru Ueba; Nobuharu Kunita; Kouichi Sano; Masuyo Nakai; Susumu Okubo; Kojiro Yasunaga; Nobuo Nagao


The Journal of the Japanese Association for Infectious Diseases | 1989

Inhibitory effect of inositol hexasulfate and inositol hexaphosphoric acid (phytic acid) on the proliferation of the human immunodeficiency virus (HIV) in vitro

Toru Otake; Haruyo Shimonaka; Motoko Kanai; Keiichi Miyano; Noboru Ueba; Nobuharu Kunita; Takashi Kurimura


Medical Entomology and Zoology | 1999

大阪府における日本脳炎(日脳)の生態学的研究 : 5. 環境条件とコガタアカイエカの発生量, 及び日脳ウイルス分離成績

Hiroshi Nakamura; Masahiro Yoshida; Akio Kimura; Takahiro Yumisashi; Tomoaki Kimura; Noboru Ueba; Nobuharu Kunita

Collaboration


Dive into the Noboru Ueba's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Toru Otake

Osaka University of Pharmaceutical Sciences

View shared research outputs
Top Co-Authors

Avatar

Haruyo Mori

Osaka University of Pharmaceutical Sciences

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Susumu Okubo

Kansai Medical University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge